PK/PD
Showing 1 - 25 of >10,000
Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)
Not yet recruiting
- Metastatic Lung Cancer
- +2 more
- Tusamitamab ravtansine
-
Rotterdam, NetherlandsErasmus MC
Jan 26, 2023
Mechanically Ventilated Patients Trial in Wuhan (Remimazolam besylate)
Not yet recruiting
- Mechanically Ventilated Patients
- Remimazolam besylate
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Nov 23, 2023
Cigarette Smoking-Related Carcinoma Trial (Vape device, Joint, Marijuana via vape device)
Not yet recruiting
- Cigarette Smoking-Related Carcinoma
- Vape device
- +3 more
- (no location specified)
Sep 19, 2023
Neonatal Infection Trial in Aurora (Amoxicillin, Cephalexin)
Enrolling by invitation
- Neonatal Infection
-
Aurora, ColoradoChildren's Hospital Colorado
Nov 2, 2022
The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal
Completed
- Fungal Infection
- Deoxycholic acid amphotericin B
-
Nanjing, Jiangsu, China
- +1 more
Nov 29, 2022
Healthy Trial in Mahesana (Omalizumab 150mg)
Recruiting
- Healthy
- Omalizumab 150mg
-
Mahesana, Gujarat, IndiaRegistered BE centre
Nov 4, 2022
Hereditary Angioedema Trial in Adelaide (ADX-324, Placebo)
Recruiting
- Hereditary Angioedema
- ADX-324
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jan 10, 2023
Healthy Trial in Ahmedabad, Mahesana (ADL-018, US-licensed XOLAIR, EU-Approved XOLAIR)
Recruiting
- Healthy
- ADL-018
- +2 more
-
Ahmedabad, Gujarat, India
- +1 more
Sep 29, 2022
Healthy Trial in Shanghai (SR1375 capsules, Placebo)
Active, not recruiting
- Healthy
- SR1375 capsules
- Placebo
-
Shanghai, ChinaPhase I clinical laboratory of Huashan Hospital
Jul 14, 2022
Renal Replacement Therapy Trial in Guangzhou (HSK36273, Heparin sodium)
Not yet recruiting
- Renal Replacement Therapy
- HSK36273
- Heparin sodium
-
Guangzhou, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Nov 1, 2022
Thrombosis Trial in Perth (SRSD107, Placebo)
Not yet recruiting
- Thrombosis
- SRSD107
- Placebo
-
Perth, Other (Non U.s.), AustraliaLinear Clinical Research
Nov 2, 2023
Opioid Overdose Trial (intradermal naloxone, microneedle injection)
Not yet recruiting
- Opioid Overdose
- intradermal naloxone
- microneedle injection
- (no location specified)
May 24, 2023
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)
Recruiting
- Non Hodgkin Lymphoma
- +3 more
-
Washington, District of Columbia
- +5 more
Nov 29, 2022
Propofol in Patients With Severe Burns
Terminated
- Anesthesia
- +2 more
- Propofol
- BIS
-
Santiago, RegiĆ³n Metropolitana, ChileVictor Contreras
Mar 7, 2022
Aminoglycoside Dosing Based on PK/PD Characteristics Trial in Jerusalem (Aminoglycoside dose adjustment)
Recruiting
- Aminoglycoside Dosing Based on PK/PD Characteristics
- Aminoglycoside dose adjustment
-
Jerusalem, IsraelHadassah Hebrew University Medical Center
Nov 8, 2022
Gastro Esophageal Reflux Trial (Lansoprazole 15 mg, Lansoprazole 15mg/Calcium carbonate 600mg)
Not yet recruiting
- Gastro Esophageal Reflux
- Lansoprazole 15 mg
- Lansoprazole 15mg/Calcium carbonate 600mg
- (no location specified)
Sep 3, 2023
BPD - Bronchopulmonary Dysplasia, Pulmonary Hypertension, NEC Trial (L-Citrulline)
Not yet recruiting
- BPD - Bronchopulmonary Dysplasia
- +2 more
- L-Citrulline
- (no location specified)
Nov 23, 2022
Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)
Completed
- Healthy Volunteers
- CMAB007
- Xolair
-
Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 8, 2023
Alopecia Areata Trial (Ritlecitinib 20 mg)
Not yet recruiting
- Alopecia Areata
- Ritlecitinib 20 mg
- (no location specified)
Dec 6, 2022
Solid Tumor, Adult Trial in Beijing, Shanxi, Shenzhen (ABO2011 Injection)
Recruiting
- Solid Tumor, Adult
- ABO2011 Injection
-
Beijing, China
- +2 more
Oct 13, 2023